Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-02-04 | New | Yet to Sell | $0 | Other | 06b | SEC link |
| 2026-02-04 | New | $6,090,946 | Unknown | Equity Only | SEC link |
| Name | Role |
|---|---|
| Robert Berman | Director |
| Zia Huque | Director |
| Andrew Kruegel | Director, Executive |
| Amy Kruse | Director |
| Phil Skolnick | Director |
| Jonathan Sporn | Director, Executive |